IGFBP1 has previously been linked to diabetes/insulin regulation, as lower circulating levels of IGFBP1 have been associated with impaired glucose tolerance, insulin resistance, diabetes, and cardiovascular diseases in mouse models [64]. Here, IGFBP1 is linked to cardiovascular disorder.